Literature DB >> 6202240

[Balloon occluded arterial infusion therapy for malignant hepatic tumors].

M Kawabata, S Takashima, K Mitsuzane, M Tanaka, C Maeda, J Hamachi, S Nomura, M Toshiyuki, N Kobayashi, M Sato.   

Abstract

A number of reports of regional intraarterial infusion chemotherapy for malignant tumors have been published. Balloon occluded arterial infusion was newly developed by us. Balloon catheter is used for temporal occlusion of the hepatic artery during intraarterial infusion of anticancer drugs. Interruption of the arterial blood flow keeps the drugs at high concentration for a long time in the distal artery to the occluded portion. This procedure has been performed in 87 cases of hepatomas and metastatic liver cancers with the sufficiently good results.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6202240

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN： 0385-0684


  4 in total

1.  Ruptured high flow gastric varices with an intratumoral arterioportal shunt treated with balloon-occluded retrograde transvenous obliteration during temporary balloon occlusion of a hepatic artery.

Authors:  Motoki Nakai; Morio Sato; Hirohiko Tanihata; Tetsuo Sonomura; Shinya Sahara; Nobuyuki Kawai; Masashi Kimura; Masaki Terada
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

2.  Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases.

Authors:  Y Ku; M Tominaga; T Iwasaki; T Kitagawa; I Maeda; M Shiotani; S Kusunoki; Y Maekawa; M Samizo; T Fukumoto; Y Kuroda; S Hirota; Y Saitoh
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Balloon-occluded arterial infusion therapy in the treatment of primary and recurrent gynecologic malignancies.

Authors:  Y Yamashita; M Takahashi; H Bussaka; Y Korogi; R Saito; K Miyazaki; S Fujisaki; H Okamura
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jul-Aug       Impact factor: 2.740

4.  Effect of gelonin immunoconjugate with monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vivo.

Authors:  Y Kaneta; K Tsukazaki; K Kubushiro; R Aoki; M Sakayori; M Ueda; S Nozawa
Journal:  Jpn J Cancer Res       Date:  1998-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.